Tweet
Exercise just as good as drugs in war on major disease
By Laura Donnelly, Health Correspondent1:00PM GMT 13 Dec 2013 Comments115 Comments
Exercise could be as effective as some of the best drugs which protect against major diseases, research has found.
A study of more than 300 trials has found that physical activity was better than medication in helping patients recovering from strokes - and just as good as drugs in protecting against diabetes and in stopping heart disease worsening.
The research, published in the British Medical Journal, analysed data about studies on 340,000 patients diagnosed with one of four diseases: heart disease, chronic heart failure, stroke or diabetes.
Researchers said the findings suggested that regular exercise could be "quite potent" in improving survival chances, but said that until more studies are done, patients should not stop taking their tablets without taking medical advice.
The landmark research compared the mortality rates of those prescribed medication for common serious health conditions, with those who were instead enrolled on exercise programmes.
Most of the 305 studies examined involved patients had been given drugs to treat their condition. But 57 of the trials - involving 15,000 volunteers - examined the impact of exercise as a treatment.
The research found that while medication worked best for those who had suffered heart failure, in all the other groups of patients, exercise was at least as effective as the drugs which are normally prescribed.
People with heart disease who exercised but did not use commonly prescribed medications, including statins, and drugs given to reduce blood clots had the same risk of dying as patients taking the medication.
Similarly, people with borderline diabetes who exercised had the same survival chances as those taking the most commonly prescribed drugs.
Drugs compared with exercise included statins, which are given to around five million patients suffering from heart disease, or an increased risk of the condition.
The study was carried out by researcher Huseyin Naci of LSE Health, London School of Economics and Political Science and Harvard Medical School, with US colleagues at Stanford University School of Medicine.
By Laura Donnelly, Health Correspondent1:00PM GMT 13 Dec 2013 Comments115 Comments
Exercise could be as effective as some of the best drugs which protect against major diseases, research has found.
A study of more than 300 trials has found that physical activity was better than medication in helping patients recovering from strokes - and just as good as drugs in protecting against diabetes and in stopping heart disease worsening.
The research, published in the British Medical Journal, analysed data about studies on 340,000 patients diagnosed with one of four diseases: heart disease, chronic heart failure, stroke or diabetes.
Researchers said the findings suggested that regular exercise could be "quite potent" in improving survival chances, but said that until more studies are done, patients should not stop taking their tablets without taking medical advice.
The landmark research compared the mortality rates of those prescribed medication for common serious health conditions, with those who were instead enrolled on exercise programmes.
Most of the 305 studies examined involved patients had been given drugs to treat their condition. But 57 of the trials - involving 15,000 volunteers - examined the impact of exercise as a treatment.
The research found that while medication worked best for those who had suffered heart failure, in all the other groups of patients, exercise was at least as effective as the drugs which are normally prescribed.
People with heart disease who exercised but did not use commonly prescribed medications, including statins, and drugs given to reduce blood clots had the same risk of dying as patients taking the medication.
Similarly, people with borderline diabetes who exercised had the same survival chances as those taking the most commonly prescribed drugs.
Drugs compared with exercise included statins, which are given to around five million patients suffering from heart disease, or an increased risk of the condition.
The study was carried out by researcher Huseyin Naci of LSE Health, London School of Economics and Political Science and Harvard Medical School, with US colleagues at Stanford University School of Medicine.
Telegraph
Comment